ACERUS PHARMACEUTICALS CORP
Profile
Company Names
ACERUS PHARMACEUTICALS CORP
TRIMEL PHARMACEUTICALS CORP
Addresses
2486 DUNWIN DRIVE, MISSISSAUGA, A6 L5L 1J9
2488 DUNWIN DRIVE, MISSISSAUGA, A6 L5L 1J9
Phone Numbers
416 679 0771
1 416 679 0771
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2009
State Incorporated:
ONTARIO, CANADA
Total Amount Raised:
$10,979,114.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2016-04-27
$2,000,000.00
$2,000,000.00
$0.00
Equity
2
2014-07-30
$2,131,268.00
$2,131,268.00
$0.00
Equity
1
2011-07-14
$6,847,846.00
$12,026,355.00
$5,178,509.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NATHAN
BRYSON
EXECUTIVE OFFICER
JAMES
BUTLER
DIRECTOR
BORYS
CHABURSKY
DIRECTOR
MATTHEW
HAWKINS
EXECUTIVE OFFICER
SNAP ADVANCES LLC
| SNAP FINANCE LLC
| TRIMEL PHARMACEUTICALS CORP
| SNAP FINANCE HOLDINGS, LLC
| ACERUS PHARMACEUTICALS CORP
| BNVC GROUP HOLDINGS, INC.
| CRESCO CAPITAL PARTNERS II, LLC
| CLICKLEASE, LLC
| HARRISON STREET TACTICAL REAL ESTATE SECURITIES FUND, L.P.
| FLRISH, INC.
| HARRISON STREET CORE PROPERTY FUND, L.P.
| HARRISON STREET CORE PROPERTY FUND A, L.P.
| HARRISON STREET CORE PROPERTY FUND C, L.P.
| HARRISON STREET CORE PROPERTY FUND F, L.P.
| ENTOURAGE EFFECT CAPITAL OPPORTUNITY FUND III B, LP
| ENTOURAGE EFFECT CAPITAL OPPORTUNITY FUND III, LP
| ENTOURAGE EFFECT ILP III, LLC
| FACIBLE BIODIAGNOSTICS, INC.
| SNAP U.S. HOLDINGS, LLC
| COLLIERS ENGINEERING + DESIGN, INC.
| ORDERPROTECTION.COM, INC.
IAN
IHNATOWYCZ
DIRECTOR
ROLF
K.
REININGHAUS
EXECUTIVE OFFICER, DIRECTOR
TOM
ROSSI
EXECUTIVE OFFICER, DIRECTOR
JEFFREY
SHERMAN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
